P42 Nurse-led safe switching from original reference product infliximab to a biosimilar in patients with juvenile idiopathic arthritis and uveitis: a single centre experience where baseline and post-switch infliximab levels and antibodies were obtained. (8th October 2018) - Fell, Andrew; Carson, Emma; Gillian, Coyle; Martin, Neil; Walsh, Jo; Gardner-Medwin, Janet